Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000246416 | SCV000520449 | benign | not specified | 2018-02-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000474584 | SCV000563085 | benign | Developmental and epileptic encephalopathy 94 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313980 | SCV000848930 | likely benign | Inborn genetic diseases | 2018-07-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV000246416 | SCV002071219 | benign | not specified | 2017-12-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001700021 | SCV002545316 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | CHD2: BP4, BS1, BS2 |
Fulgent Genetics, |
RCV000474584 | SCV002808871 | likely benign | Developmental and epileptic encephalopathy 94 | 2022-04-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001700021 | SCV005214039 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004529426 | SCV000307180 | benign | CHD2-related disorder | 2021-03-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001700021 | SCV001927053 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700021 | SCV001966956 | likely benign | not provided | no assertion criteria provided | clinical testing |